Get the Stockscreener App
1.3495
3.26%
-0.0455
After Hours:
1.35
0.0005
+0.04%
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Forecast
The X T L Biopharmaceuticals Ltd Adr (XTLB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.2002, representing a +63.04% increase from the current price of $1.3495. The highest analyst price target is $2.5753, and the lowest is $1.8251.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XTLB Price Target
Average 4.3719
(+223.96% Upside)
Is X T L Biopharmaceuticals Ltd Adr (XTLB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.75 | Neutral |
| STOCH(9,6) | 75.95 | Neutral |
| STOCHRSI(14) | 59.53 | Neutral |
| MACD(12,26) | -0.0179 | Buy |
| ADX(14) | 20.94 | Neutral |
| William %R | -40.60 | Neutral |
| CCI(14) | 72.29 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.2931
Buy
|
1.3202
Buy
|
| MA20 |
1.2851
Buy
|
1.3229
Buy
|
| MA50 |
1.4381
Sell
|
1.3548
Sell
|
| MA100 |
1.3277
Buy
|
1.38
Sell
|
| MA200 |
1.4584
Sell
|
1.5582
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, XTLB could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on XTLB, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 50.75 indicates that XTLB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 75.95 indicates that XTLB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 59.53 indicates that XTLB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.94 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 72.29 indicates that XTLB is still overbought but not to an extreme extent.
Long-term XTLB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about X T L Biopharmaceuticals Ltd Adr financial reports and earnings history, X T L Biopharmaceuticals Ltd Adr (XTLB) stock could reach $2.7706 by 2030, $2.0587 by 2040 and $3.4995 by 2050. See the projected annual prices until 2050 of the X T L Biopharmaceuticals Ltd Adr stock below:
- X T L Biopharmaceuticals Ltd Adr (XTLB) is expected to reach an average price of $1.4173 in 2035, with a high prediction of $1.6072 and a low estimate of $1.3926. This indicates an $5.03% rise from the last recorded price of $1.3495.
- X T L Biopharmaceuticals Ltd Adr (XTLB) stock is projected to chart a bullish course in 2040, with an average price target of $1.9493, representing an $44.45% surge from its current level. The forecast ranges from a conservative $1.8589 to a sky-high $2.0587.
- Our analysts predict X T L Biopharmaceuticals Ltd Adr (XTLB) to jump 69.47% by 2045, soaring from $2.1563 to an average price of $2.287, potentially reaching $2.4368. While $2.1563 is the low estimate, the potential upside is significant.
- X T L Biopharmaceuticals Ltd Adr (XTLB) stock is expected to climb by 2050, reaching an average of $2.9405, a $117.89% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.4995 and $2.6402, respectively, highlighting the market's uncertainty.
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Year by Year Forecast
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2025
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) is expected to reach an average price of $1.8871 in 2025, with a high prediction of $2.9259 and a low estimate of $0.8483. This indicates an +39.83% rise from the last recorded price of $1.3495.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2025 | $2.2954 | $1.8251 | $2.5753 | +70.09% |
| November, 2025 | $2.3756 | $1.9566 | $2.4946 | +76.04% |
| December, 2025 | $2.556 | $2.0957 | $2.9259 | +89.40% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2026
The predicted value for X T L Biopharmaceuticals Ltd Adr (XTLB) in 2026 is set at an average of $4.6924. Estimates vary from a peak of $6.9187 to a trough of $2.4661, indicating an +247.71% surge from the present price of $1.3495.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.6358 | $2.4661 | $2.7663 | +95.31% |
| February, 2026 | $3.2565 | $2.4963 | $3.6265 | +141.32% |
| March, 2026 | $3.3368 | $3.2466 | $4.3967 | +147.26% |
| April, 2026 | $3.9772 | $2.9372 | $6.3372 | +194.71% |
| May, 2026 | $3.5575 | $3.3772 | $4.0372 | +163.61% |
| June, 2026 | $3.4377 | $3.1777 | $3.8176 | +154.74% |
| July, 2026 | $3.7585 | $3.3398 | $4.0378 | +178.51% |
| August, 2026 | $3.8184 | $3.4333 | $4.0284 | +182.95% |
| September, 2026 | $4.6787 | $3.5086 | $6.9187 | +246.70% |
| October, 2026 | $4.819 | $3.5688 | $5.429 | +257.09% |
| November, 2026 | $4.7193 | $4.3591 | $5.8792 | +249.70% |
| December, 2026 | $4.1696 | $4.0496 | $4.7893 | +208.97% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for X T L Biopharmaceuticals Ltd Adr (XTLB) is $3.1961, with a high forecast of $4.8097 and a low forecast of $1.5825. This indicates an +136.84% increase from the last price of $1.3495.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.1999 | $3.8298 | $4.8097 | +211.22% |
| February, 2027 | $3.4302 | $3.1901 | $4.19 | +154.18% |
| March, 2027 | $3.0005 | $2.7909 | $3.6802 | +122.34% |
| April, 2027 | $2.6708 | $2.4808 | $3.2307 | +97.91% |
| May, 2027 | $2.611 | $2.5012 | $2.8323 | +93.48% |
| June, 2027 | $2.4314 | $2.2814 | $2.7511 | +80.17% |
| July, 2027 | $2.4393 | $2.2915 | $2.8815 | +80.76% |
| August, 2027 | $2.332 | $2.072 | $2.7018 | +72.80% |
| September, 2027 | $1.9523 | $1.712 | $2.252 | +44.67% |
| October, 2027 | $1.7516 | $1.5825 | $2.0124 | +29.80% |
| November, 2027 | $1.9229 | $1.6827 | $2.0429 | +42.49% |
| December, 2027 | $1.8432 | $1.723 | $2.4531 | +36.59% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2028
In 2028, X T L Biopharmaceuticals Ltd Adr (XTLB) is projected to reach an average price of $1.0334, with a high projection of $1.8333 and a low estimate of $0.2335. This indicates an -23.42% fall from the last price of $1.3495.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2335 | $0.2335 | $1.8333 | -82.70% |
| February, 2028 | $1.4388 | $1.084 | $1.7036 | +6.62% |
| March, 2028 | $1.6241 | $1.3568 | $1.6941 | +20.35% |
| April, 2028 | $1.4598 | $1.4381 | $1.7342 | +8.17% |
| May, 2028 | $1.6248 | $1.2746 | $1.6248 | +20.40% |
| June, 2028 | $1.405 | $1.395 | $1.6349 | +4.12% |
| July, 2028 | $1.58 | $1.4251 | $1.6853 | +17.08% |
| August, 2028 | $1.4457 | $1.4056 | $1.6455 | +7.13% |
| September, 2028 | $1.4559 | $1.3657 | $1.7759 | +7.89% |
| October, 2028 | $1.5562 | $1.2961 | $1.6262 | +15.32% |
| November, 2028 | $1.5366 | $1.3666 | $1.5866 | +13.86% |
| December, 2028 | $1.2569 | $1.157 | $1.5766 | -6.87% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2029
The 2029 price forecast for X T L Biopharmaceuticals Ltd Adr Stock (XTLB) is $3.1083 on average, with a high prediction of $5.2295 and a low estimate of $0.987. This represents an +130.33% increase from the previous price of $1.3495.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.0274 | $0.987 | $1.2769 | -23.87% |
| February, 2029 | $1.2111 | $0.9973 | $1.3274 | -10.25% |
| March, 2029 | $1.1354 | $1.0578 | $1.2877 | -15.87% |
| April, 2029 | $1.0581 | $1.0128 | $1.2528 | -21.59% |
| May, 2029 | $1.2484 | $0.9881 | $1.2684 | -7.49% |
| June, 2029 | $1.1787 | $1.1539 | $1.3686 | -12.66% |
| July, 2029 | $1.1099 | $0.9987 | $1.4089 | -17.75% |
| August, 2029 | $1.1093 | $1.0392 | $1.1612 | -17.80% |
| September, 2029 | $1.1396 | $1.0076 | $1.1893 | -15.56% |
| October, 2029 | $3.4999 | $1.0846 | $5.2295 | +159.35% |
| November, 2029 | $2.8302 | $2.5901 | $3.475 | +109.72% |
| December, 2029 | $2.5954 | $2.5903 | $2.9201 | +92.32% |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Price Forecast for 2030
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) is expected to reach an average price of $1.9211 in 2030, with a high forecast of $2.7706 and a low forecast of $1.0715. This signifies an +42.35% surge from the last price of $1.3495.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.441 | $2.3404 | $2.7706 | +80.88% |
| February, 2030 | $2.3915 | $2.2213 | $2.6015 | +77.22% |
| March, 2030 | $2.3421 | $2.152 | $2.482 | +73.55% |
| April, 2030 | $2.3355 | $2.0726 | $2.4095 | +73.07% |
| May, 2030 | $1.7573 | $1.7573 | $2.2731 | +30.22% |
| June, 2030 | $1.7559 | $1.6939 | $2.0336 | +30.11% |
| July, 2030 | $1.7078 | $1.644 | $1.8342 | +26.55% |
| August, 2030 | $1.7252 | $1.6677 | $2.0649 | +27.84% |
| September, 2030 | $1.9457 | $1.6453 | $2.2306 | +44.18% |
| October, 2030 | $1.2864 | $1.2772 | $1.9961 | -4.68% |
| November, 2030 | $1.4428 | $1.0715 | $1.6468 | +6.91% |
| December, 2030 | $1.6475 | $1.3622 | $1.8075 | +22.08% |
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):